Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.93 USD | +7.05% | +11.02% | +63.38% |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Mar. 28 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
Financials (USD)
Sales 2024 * | 38.86M | Sales 2025 * | 57.15M | Capitalization | 2.46B |
---|---|---|---|---|---|
Net income 2024 * | -188M | Net income 2025 * | -217M | EV / Sales 2024 * | 63.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 43.1 x |
P/E ratio 2024 * |
-13.2
x | P/E ratio 2025 * |
-12.4
x | Employees | 201 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.53% |
1 day | +7.05% | ||
1 week | +11.02% | ||
Current month | -0.22% | ||
1 month | +0.38% | ||
3 months | +31.76% | ||
6 months | +121.11% | ||
Current year | +63.38% |
Managers | Title | Age | Since |
---|---|---|---|
Bill Lundberg
CEO | Chief Executive Officer | 60 | 19-06-11 |
Gregory Perry
DFI | Director of Finance/CFO | 63 | 16-04-30 |
Chief Tech/Sci/R&D Officer | - | 16-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Perry
DFI | Director of Finance/CFO | 63 | 16-04-30 |
Maxine Gowen
BRD | Director/Board Member | 66 | 21-05-27 |
Paolo Pucci
BRD | Director/Board Member | 63 | 20-06-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 44.93 | +7.05% | 1,921,425 |
24-04-24 | 41.97 | +2.82% | 741,293 |
24-04-23 | 40.82 | +0.91% | 572,348 |
24-04-22 | 40.45 | +1.61% | 705,458 |
24-04-19 | 39.81 | -1.63% | 795,015 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.38% | 2.46B | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- MRUS Stock